Dual AntiPlatelet Therapies for Prevention of Periinterventional Embolic Events in TAVI

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT03001960

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03001960
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03001960. Randomized; double masking; primary purpose treatment. Start 2017-03 (registry gives no type); primary completion 2018-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Dual AntiPlatelet Therapies for Prevention of Periinterventional Embolic Events in TAVI
Acronym
DAPT-TAVI
Condition
Aortic Valve Stenosis
Condition
Intracranial Embolism
Intervention (Drug)
Preloading before TAVI
Intervention (Drug)
Postloading after TAVI
Lead sponsor
Charite University, Berlin, Germany (class: other)
Collaborator
Prof. Dr. Jochen Fiebach, Center for Stroke Research Berlin (CSB), Charité - Universitaetsmedizin Berlin (class: not stated)

Record details

Record id
cardio:ct-nct03001960
Content hash
83f23e36c017f098ba704dec8e0405e5364574643ca255ccb08a738fae2c31c9